Recurrent response to advanced lung adenocarcinoma with erlotinib developing leptomeningeal metastases during gefitinib therapy and two case reports

BACKGROUND: Epidermal growth factor-tyrosine kinase inhibitors (EGFR-TKIs) are one of the effective medicines in advanced lung adenocarcinoma leptomeningeal metastasis (LM) treatment in recent years. METHODS: This paper reports two cases of advanced lung adenocarcinoma with exon-EGFR19 mutation. LM...

全面介紹

Na minha lista:
書目詳細資料
發表在:Thorac Cancer
Main Authors: Xing, Puyuan, Li, Junling, Shi, Yuankai, Zhang, Xiangru
格式: Artigo
語言:Inglês
出版: BlackWell Publishing Ltd 2014
主題:
Original Articles
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC4704275/
https://ncbi.nlm.nih.gov/pubmed/26766970
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.12049
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍